ArticleJournal of the colleges of medicine of South Africa2025
Diabetic Ketoacidosis and COVID-19: Patient profiles from a regional emergency department in Johannesburg, South Africa.
Article in Journal of the colleges of medicine of South Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to describe the clinical features and severity of illness in patients diagnosed with both coronavirus disease 2019 (COVID-19) and diabetic ketoacidosis (DKA) at a South African regional hospital. Methods: This was a single centre, retrospective, observational study conducted at a regional hospital in Johannesburg, South Africa. Records of patients who presented to the emergency department (ED) between 01 April 2020 to 31 August 2021 and were diagnosed with DKA were reviewed. Both COVID-19 positive and negative patients were included. Results: Of the 104 patients with DKA, 35 (33.7%) tested positive for COVID-19. Among the COVID-19 positive group, two required ICU admission and two were admitted to the High Care Unit (HCU). Interventions included high-flow nasal cannula (1 patient), intubation (2 patients), and inotropic support (1 patient). Outcomes included one death (2.9%), one patient declining treatment, and one transfer. A statistically significant association was found between the COVID-19 positive group and increased age ( Conclusion: This retrospective study demonstrated that patients with COVID-19 and DKA had a lower mortality rate than previously described. In patients with both COVID-19 and DKA, a significant association with advanced age and DMT2 was noted. Contribution: Data on the burden of co-existing DKA and COVID-19 in South Africa remain limited. This study contributes by highlighting a lower observed mortality rate and underscores the need for further local research on this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.